Researchers Test Nintedanib in Mesothelioma Clinical Trial
Medical oncologist Dr. Rama Balaraman isn’t expecting any miracles from the pleural mesothelioma clinical trial involving nintedanib, the small-molecule enzyme inhibitor. She is expecting progress. Balaraman, at Florida Cancer Affiliates in Ocala, is participating in an international, multicenter trial that will expand the use of nintedanib within the U.S., giving patients another weapon in this…
The post Researchers Test Nintedanib in Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.